Xenon Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Xenon Pharmaceuticals has a total shareholder equity of $927.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $964.8M and $36.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$638.08m |
Equity | US$927.92m |
Total liabilities | US$36.88m |
Total assets | US$964.80m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: XP0's short term assets ($645.0M) exceed its short term liabilities ($27.3M).
Long Term Liabilities: XP0's short term assets ($645.0M) exceed its long term liabilities ($9.6M).
Debt to Equity History and Analysis
Debt Level: XP0 is debt free.
Reducing Debt: XP0 has no debt compared to 5 years ago when its debt to equity ratio was 14.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XP0 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: XP0 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 32.9% each year